Qandli diabetning 2-turini biguanid guruh preparatlari bilan davolashda mikrobiota holatining o'zgarishi

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/7701

Full metadata record

DC Field	Value	Language
dc.contributor.author	Shagazatova B.X., Vafoyev Sh.F.	-
dc.date.accessioned	2023-05-08T06:16:36Z	-
dc.date.available	2023-05-08T06:16:36Z	-
dc.date.issued	2023	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/7701	-
dc.description.abstract	Qandli diabet (QD) juda keng tarqalgan kasallik bo‘lib, insulin ishlab chiqarilishining kamayishi yoki uning to‘qimalar tomonidan sezuvchanligi pasayishi ya’ni rezistentligi natijasida kelib chiqadi. Qandli diabet 2 tur hamma uchrovchi diabetlarning 90% ini tashkil qiladi. Xalqaro Diabet Assotsiatsiyasining bergan ma’lumotlariga ko‘ra, 537 million katta yoshdagilar (20-79 yosh) qandli diabet bilan xastalangan. Bu raqamlar 2030 yilda 643 million va 2045 yilda 783 millionga yetishi taxmin qilinmoqda. 2021 yilda 6.7 million bemor qandli diabet tufayli vafot etdi. 541 million yoshi kattalar esa glyukozaga tolerantlikning buzilishidan aziyat chekadi.	en_US
dc.language.iso	other	en_US
dc.publisher	Ўзбекистон, Тошкент	en_US
dc.title	Qandli diabetning 2-turini biguanid guruh preparatlari bilan davolashda mikrobiota holatining o'zgarishi	en_US
dc.type	Thesis	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
Сборник тезисов_removed.pdf	Qandli diabetning 2-turini biguanid guruh preparatlari bilan davolashda mikrobiota holatining o'zgarishi	816.38 kB	Adobe PDF	View/Open

DSpace JSPUI